Brolucizumab
Products Brolucizumab was approved as a solution for injection in the United States in 2019 and in many countries in 2020 (Beovu). Structure and properties Brolucizumab is a humanized monoclonal antibody fragment with a single Fv chain (single-chain antibody fragment, scFv). The molecular mass is in the range of 26 kDa. It is significantly lower … Brolucizumab
